Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

In Vitro Diagnostics (IVD) News: Breaking In Vitro Diagnostics (IVD) News, Comments and Articles. - Page: 5

23:53 EDT 23rd April 2014 | BioPortfolio

In Vitro Diagnostics (IVD) News - Page: 5Twitter RSS

Read the latest In Vitro Diagnostics (IVD) News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on In Vitro Diagnostics (IVD).

Search or Follow Our In Vitro Diagnostics (IVD) - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More In Vitro Diagnostics (IVD) - Page: 5 News.
You can also follow our In Vitro Diagnostics (IVD) - Page: 5 news stories on Twitter: @IVDiagnostics

Showing "invitro diagnostics vitro" News Articles 101 to 125 of 3,900+

Friday 18th April 2014

SPIE Translational Biophotonics Aims to Help Deliver Better Treatments to Patients Faster

Delivering better treatments to patients faster is the ultimate goal of SPIE Translational Biophotonics, a new workshop scheduled for 19-20 May on the Rice University campus in Houston, Texas. The workshop will bring together academics, industry R&D leaders, and practicing clinicians for presentations on technologies with applications in cancer diagnostics, cardiovascular imaging, and detecti...

Sanovas Fortifies Patent Estate for its "Smart Catheter" Portfolio: Resector Balloon System Patent Strengthens Vas Zeppelin™ Platform

SAUSALITO, Calif., April 18, 2014 /PRNewswire/ -- Sanovas Inc. (www.sanovas.com), a Life Sciences Accelerator developing and commercializing next-generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that it has been awarded U.S. Patent No. 8,696,621 for its Resector Balloon System for removing undesirable biological material, such as tumors, within bo...

Research report on flow cytometry market

According to the new market research report "Flow Cytometry Market by Technology (Cell & Bead-based), Products & Services (Reagents, Instruments, Software, & Accessories), Application (Research & Clinical), End User (Commercial Organizations & Diagno...

Flow Cytometry Market worth $3.7 Billion in 2018

DALLAS, April 17, 2014 /PRNewswire/ -- According to the new market research report "Flow Cytometry Market by Technology (Cell & Bead-based), Products & Services (Reagents, Instruments, Software, & Accessories), Application (Research & Clinical), End User (Commercial Organizations & Diagnostics Laboratories) - Global Forecasts to 2018", analyzes and studies the major mark...

DNA Sequencing: Emerging Technologies and Applications

LONDON, April 17, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: DNA Sequencing: Emerging Technologies and Applicationshttp://www.reportbuyer.com/pharma_healthcare/biotechnology/technologies/dna_sequencing_emerging_technologies_applications.html REPORT HIGHLIGHTSThe global market for sequencing products and services reached $3.5 billion in 2012. This market is expec...

Lumiphore advances its site-directed radiopharmaceutical development program with the receipt of an NSF SBIR Phase II Grant

BERKELEY, Calif., April 17, 2014 /PRNewswire-iReach/ -- Lumimphore Inc., a pharmaceutical leader in bifunctional chelator design, is developing in vivo radio-diagnostic imaging and site-directed radio-therapeutics, using its proprietary bifunctional radionuclide metal-chelation technology; it has received a National Science Foundation Small Business Innovation Research (SBIR) Phase II Grant entit...

Cancer Profiling and Pathways: Technologies and Global Markets

WEST HARTFORD, Conn., April 17, 2014 /PRNewswire-iReach/ -- Global Information Inc. announces the addition of a new market research report "Cancer Profiling and Pathways: Technologies and Global Markets" at GIIResearch.com The global market for cancer profiling technologies reached $26.1 billion in 2012. This market is expected to grow to nearly $30.1 billion in 2013 and $54.8 billion in 2018,...

Thursday 17th April 2014

Saint-Gobain Seals’ Rulon® 1439 Material Certified as USP Class VI Compliant, Further Meeting Needs of Medical Device and Pharmaceutical Processing

Garden Grove, CA, April 18, 2014 --(PR.com)-- Saint-Gobain Seals’ Rulon® 1439 material has achieved full USP Class VI certification, complying with stringent disposable and reusable medical device requirements. USP (United States Pharmacopeia) is an independent public health organization that promotes public health by establishing state-of-the-art standards, and USP Class VI compliance...

Quest Launches Website Enabling Patients to Access Lab Data under New Federal Rule that takes effect today

For the first time, Americans nationwide can directly access their personal laboratory data through Quest Diagnostics, the world's leading provider of diagnostic information services. Quest Diagnostics provides diagnostic information services to about 30% of American adults each year. Under a federal rule that went into effect last week, patients in all 50 states and the District of Columbia...

SCRA Technology Ventures announces sale of Selah Genomics to EKF Diagnostics

SCRA Technology Ventures today announced that portfolio company Selah Genomics was sold to EKF Diagnostics, a publically-traded UK-based diagnostics firm. Selah, a provider of advanced molecular and genomic diagnostic services, completed the deal tod...

FDA Approves Merck’s RAGWITEK™ (Short Ragweed Pollen Allergen Extract) Sublingual Tablet as Immunotherapy to Treat Short Ragweed Pollen-Induced Allergic Rhinitis with or without Conjunctivitis in Adults

RAGWITEK is the First and Only FDA Approved Sublingual Allergen Immunotherapy Tablet Indicated for the Treatment of Short Ragweed Pollen Allergies Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved RAGWITEK™ (Short Ragweed Pollen Allergen Extract) Tablet f...

Double-stapled peptide inhibits Respiratory syncytial virus infection

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections, generating life-threating illness in very young and elderly populations. Despite great effort, preventive therapies are limited. RSV enters host cells throug...

SC Launch Portfolio Company Announces Acquisition

Upstate-based Selah Genomics Inks $75 Million Deal SCRA Technology Ventures today announced that portfolio company Selah Genomics was sold to EKF Diagnostics, a publically-traded UK-based diagnostics firm. Selah, a provider of advanced molecular and genomic diagnostic services, completed the deal today, making it the largest of nine exits out of the SC...

NF-κB Activity Is Required for Anagen Maintenance in Human Hair Follicles In Vitro

Poop-Powered Diagnostics for Liver Condition in Newborns

Fecal color and consistency are well-known markers of digestive health in both children and adults, but paying attention to a newborn’s shade of poop can be a decided lifesaver in babies born with the rare, liver-ravaging disorder biliary atresia,...

Gene variant raises risk for aortic tear and rupture

Researchers from Yale School of Medicine and Celera Diagnostics have confirmed the significance of a genetic variant that substantially increases the risk of a frequently fatal thoracic aortic dissection or full rupture. The study appears online in P...

WoundSource Reports on the Role of NovaBay’s NeutroPhase® in Treatment of ‘Flesh-Eating’ Infections

NeutroPhase has been shown in the laboratory to neutralize the toxins that make these infections so deadly, writes Dr. Bruce E. Ruben in a WoundSource blog NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a clinical-stage biopharmaceutical company, today announced that WoundSource™ has highlighted NovaBay’s

Agilent Technologies Thought Leader Award Supports Dr. Joshua Rabinowitz’s Research at Princeton University

Team Developing LC/MS Methods, Bioinformatics Tools for Discovery of Metabolic Regulatory Mechanisms Agilent Technologies Inc. (NYSE: A) today announced that Joshua Rabinowitz, M.D., Ph.D., professor at Princeton University’s Department of Chemistry and the

Gamma Medica Creates Strategic Advisory Board Chaired by Veteran Health Technology Executive Robert Cascella

Gamma Medica, developer of advanced digital molecular imaging technologies for the detection of breast cancer, announced today that it has formed a strategic advisory board comprised of distinguished clinicians and thought leaders with expertise in women’s health technologies and diagnostic imaging. Robert Cascella, former chief executive officer of Holo...

ChanTest Announces: Webinar on the CiPA Initiative – Defining a new paradigm in the field of cardiac safety

ChanTest, in collaboration with Dr. Philip Sager, are seeking multi-stakeholder input to move towards using non-clinical in vitro human models to assess a drug’s cardiac safety Cleveland, OH (PRWEB) April 17, 2014 ChanTest, the world’s most trusted ion channel expert, announces a complementary webinar entitled “Making Sense of the CiPA Initiative: a Paradigm Shift in Cardiac Safety”. The...

Molecular Diagnostics Reports Bundle

DUBLIN, Ireland, April 17, 2014 /PRNewswire/ --read more

As Genetics Moves to the Clinic, Pathogenic Variants Still Subject to Doubt and Debate

Bio-IT World | Genetic diagnostics is a growing field with great promise for improving medical care—yet interpreting the results of tests is a painstaking process, and different labs can disagree on which variants contribute to disease. As open sci...

Targeted Medical Pharma Completes Middle East Distribution Agreement

Creates new market opportunity for increased product sales Targeted Medical Pharma (OTCQB: TRGM), today announced the completion of an agreement between Analytical Testing Laboratories (ATL), a Lebanon based company that specializes in drug testing services

Grifols Celebrates World Hemophilia Day with Donation of Coagulation Medicines to the World Federation of Hemophilia

BARCELONA, Spain, April 17, 2014 /PRNewswire/ -- Grifols, S.A. (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) today announced that it will donate up to 20 million units of coagulation therapies in each of the next three (3) years to the World Federation of Hemophilia (WFH). Grifols has been a proud supporter of the WFH and its noble efforts for nearly a decade – and this unprecedented product...

Boston Heart Granted New York Laboratory Permit for Diagnostic Testing

FRAMINGHAM, Mass., April 17, 2014 /PRNewswire/ -- Boston Heart Diagnostics Corporation, a pioneer in integrating next-generation diagnostics into personalized nutrition and lifestyle programs for patients with or at risk for heart disease, today announced that the company can serve patients from all 50 states now that it has successfully completed the New York State Department of Health (NYSDOH) c...


Search BioPortfolio:
Advertisement

News Quicklinks

Advertisement